ストックスクリーナーアプリを入手
100.05
0.59%
-0.59
アフターアワーズ：
100.21
0.16
+0.16%
Kimberly Clark Corp (KMB) 最新ニュース
Jim Cramer Notes Kimberly-Clark’s Stock Got “Clobbered” After Kenvue Acquisition Announcement - Insider Monkey
Is Kimberly Clark Corporation (KMY) stock resilient in recession scenariosMarket Trend Report & Intraday High Probability Alerts - fcp.pa.gov.br
Kimberly-Clark Stock Sell-Off Is an Overreaction After $49B Kenvue Deal - Investing.com
Sticker Shock: Why Kimberly-Clark's Sell-Off Is an Overreaction - inkl
Kimberly-Clark (NASDAQ:KMB) Price Target Cut to $110.00 by Analysts at Wells Fargo & Company - MarketBeat
Kimberly-Clark's $40 Billion Bid for Tylenol Maker Sparks Selloff, Trader Opportunity - Bloomberg.com
Huntington National Bank Purchases 4,514 Shares of Kimberly-Clark Corporation $KMB - MarketBeat
Jim Cramer Just Couldn’t Help Himself When Talking About Kimberly-Clark (KMB)’s Kenvue Acquisition - MSN
Kimberly-Clark (KVUE) Buying Kenvue Isn’t A Mistake, Asserts Jim Cramer - Insider Monkey
Machina Capital S.A.S. Has $444,000 Stock Position in Kimberly-Clark Corporation $KMB - MarketBeat
Kimberly-Clark Corporation $KMB Stock Position Trimmed by Bank of New York Mellon Corp - MarketBeat
Kimberly-Clark Corporation $KMB Stake Raised by Assetmark Inc. - MarketBeat
Kimberly-Clark bets $40 billion for Kenvue despite Tylenol controversy - MSN
Risk adjusted return profile for Kimberly Clark Corporation analyzed2025 Historical Comparison & Weekly Setup with High ROI Potential - newser.com
Kimberly-Clark to acquire Kenvue - World Aerosols
What Wall Street predicts for Kimberly Clark Corporation stock price2025 Dividend Review & Verified Entry Point Detection - newser.com
Kimberly-Clark To Acquire Kenvue In Massive $48.7B Merger - MSN
Kimberly-Clark will buy Tylenol maker Kenvue in a $48.7 billion deal - MSN
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An - GlobeNewswire
Kimberly-Clark deal a vote of confidence in Trump’s economy - Washington Times
Kimberly-Clark/Kenvue Deal: What Could Stop It - Barron's
Kenvue's $48.7 Billion Sale Puts Consumer Staples ETFs Back In Vogue - Benzinga
Analyst Robert Moskow Lowers Price Target for Kimberly-Clark (KM - GuruFocus
Kleenex Wipes Away Kenvue’s Tears: North Texas’ Kimberly-Clark To Buy Embattled Tylenol Maker - Dallas Express
Kimberly-Clark to buy Tylenol maker Kenvue in $48.7-B deal - MSN
Kimberly-Clark to acquire Tylenol maker Kenvue in $48.7 billion deal - 95.3 X95
Kimberly-Clark, Kenvue’s $48.7B deal among recent multibillion-dollar M&A - Manufacturing Dive
Kimberly-Clark (KMB) Price Target Lowered by Wells Fargo to $110 | KMB Stock News - GuruFocus
Kimberly-Clark (NASDAQ:KMB) Shares Gap Down on Analyst Downgrade - MarketBeat
Kimberly-Clark transformation adds complexity and uncertainty, says Evercore - Investing.com
The Gamble Behind a Big Takeover of Tylenol’s Maker - The New York Times
Kimberly-Clark: Can The Kenvue Acquisition Erase The Decade Of Disappointment? (KMB) - Seeking Alpha
Kimberly-Clark acquires Kenvue for USD 48.7 billion to strengthen its leadership in personal care and health - Tissue Online North America
Kimberly-Clark buys troubled Tylenol-maker Kenvue for $48.7bn - Yahoo Finance
Kenvue Stock Rose 12% On Possible $48.7 Billion Acquisition by Kimberly-Clark - TIKR.com
This Kimberly-Clark Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Benzinga
Kimberly-Clark Bets Big On Kenvue In $49 Billion Deal - Finimize
Kimberly-Clark Takeover Offers $48 Billion of Pain Relief to Tylenol-Maker Kenvue - The Daily Upside
Kenvue (KVUE) Soars 12% on $48.7-Billion Kimberly-Clark Merger - Insider Monkey
Kimberly-Clark To Acquire Kenvue In $48.7 Billion Mega Deal - Yahoo Finance
Kimberly-Clark (NASDAQ:KMB) Sets New 52-Week LowTime to Sell? - MarketBeat
Kimberly-Clark to acquire Band-Aid, Neutrogena owner Kenvue for $48.7 billion - Storyboard18
Kimberly-Clark (KMB): Assessing Value After Recent 17% Share Price Slide - Yahoo Finance
iA Global Asset Management Inc. Sells 18,949 Shares of Kimberly-Clark Corporation $KMB - MarketBeat
Kimberly-Clark Stock Drops Premarket Even As Analysts, Retail Investors Turn Positive On $49B Kenvue Deal - Stocktwits
Kimberly-Clark to buy embattled Tylenol maker Kenvue in a deal valued at more than $48 billion - MSN
Kimberly-Clark to acquire Tylenol's parent company in nearly $49B deal - NPR
Kimberly-Clark Bets $48.7B on Health Giant Kenvue - Value The Markets
Kimberly-Clark Corporation $KMB Shares Bought by Atria Investments Inc - MarketBeat
Kimberly-Clark to buy Kenvue - The Arkansas Democrat-Gazette
Can machine learning forecast Kimberly Clark Corporation recoveryEarnings Summary Report & High Accuracy Trade Signal Alerts - newser.com
Kimberly-Clark to acquire Kenvue, creating a $32 billion leader - PULPAPERnews.com
Is Kimberly Clark Corporation stock a buy in volatile marketsJuly 2025 Levels & Technical Entry and Exit Tips - newser.com
Kimberly-Clark buying Kenvue in $48.7 billion consumer brands deal - TelegraphHerald.com
Kimberly-Clark is taking Tylenol in $49 billion deal - Morning Brew
Kenvue’s Tylenol Litigation Overhang Doesn’t Dim ‘Generational Opportunity’ For Kimberly-Clark - Citeline News & Insights
Kenvue Shares Soar 16% After Inking $48.7B Deal With Kimberly-Clark - Stocktwits
Will Kimberly Clark Corporation stock outperform Dow Jones index2025 Short Interest & Fast Gaining Stock Reports - newser.com
Latham Advises on Financing for Kimberly-Clark’s Acquisition of Kenvue to Create a US$32 Billion Global Health and Wellness Leader - Legal Desire Media and Insights
1.63%
1.93%
大文字化:
|
ボリューム (24 時間):